• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Emerging roles of BRCA1 alternative splicing.BRCA1可变剪接的新作用。
Mol Pathol. 2003 Aug;56(4):191-7. doi: 10.1136/mp.56.4.191.
2
Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families.印度乳腺癌和乳腺-卵巢癌家族中BRCA1和BRCA2基因的新型种系突变。
Hum Mutat. 2004 Feb;23(2):205. doi: 10.1002/humu.9213.
3
RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain.对在西班牙乳腺癌/卵巢癌家族中鉴定出的8种BRCA1和BRCA2未分类变异进行RNA分析。
Hum Mutat. 2003 Oct;22(4):337. doi: 10.1002/humu.9176.
4
A Case Report of Germline Compound Heterozygous Mutations in the Gene of an Ovarian and Breast Cancer Patient.一例卵巢癌和乳腺癌患者基因胚系复合杂合突变的病例报告。
Int J Mol Sci. 2021 Jan 17;22(2):889. doi: 10.3390/ijms22020889.
5
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.在高危芬兰 BRCA1/2 种系突变阴性的乳腺癌和/或卵巢癌个体中筛查 BRCA1、BRCA2、CHEK2、PALB2、BRIP1、RAD50 和 CDH1 突变。
Breast Cancer Res. 2011 Feb 28;13(1):R20. doi: 10.1186/bcr2832.
6
Alternative splicing of breast cancer associated gene BRCA1 from breast cancer cell line.来自乳腺癌细胞系的乳腺癌相关基因BRCA1的可变剪接
J Biochem Mol Biol. 2007 Jan 31;40(1):15-21. doi: 10.5483/bmbrep.2007.40.1.015.
7
BRCA1: what do we know? What do we think we know? What do we really need to know?乳腺癌1号基因(BRCA1):我们知道什么?我们自认为知道什么?我们真正需要知道什么?
Gynecol Oncol. 2000 Mar;76(3):291-3. doi: 10.1006/gyno.2000.5742.
8
Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines.BRCA1剪接变体在异步及G1/S期同步化肿瘤细胞系中的表达谱
Biochem Biophys Res Commun. 2001 Jan 12;280(1):32-8. doi: 10.1006/bbrc.2000.4068.
9
A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1.针对BRCA1中一个假定剪接位点突变的特定绿色荧光蛋白(GFP)表达测定、外显率估计及组织学评估。
Hum Mutat. 2003 Jul;22(1):86-91. doi: 10.1002/humu.10224.
10
BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.BRCA1 和 BRCA2 未分类变异体及错义多态性在阿尔及利亚乳腺癌/卵巢癌家族中的研究。
Dis Markers. 2012;32(6):343-53. doi: 10.3233/DMA-2012-0893.

引用本文的文献

1
Case report: Deciphering the clinical significance of a novel partial exon 10 duplication in a patient with triple-negative breast cancer.病例报告:解读三阴性乳腺癌患者中一种新型10号外显子部分重复的临床意义。
Front Oncol. 2025 Feb 6;15:1497531. doi: 10.3389/fonc.2025.1497531. eCollection 2025.
2
Alternative splicing in ovarian cancer.卵巢癌中的可变剪接。
Cell Commun Signal. 2024 Oct 18;22(1):507. doi: 10.1186/s12964-024-01880-8.
3
BRCA1/2 mutations and outcomes among Middle Eastern patients with early-onset breast cancer in Oman.阿曼早发性乳腺癌中东患者的BRCA1/2突变与预后
Oncologist. 2024 Dec 6;29(12):e1714-e1722. doi: 10.1093/oncolo/oyae214.
4
Functional Characterization of the Human BRCA1 ∆11 Splicing Isoforms in Yeast.在酵母中对人类 BRCA1 ∆11 剪接异构体的功能进行鉴定。
Int J Mol Sci. 2024 Jul 9;25(14):7511. doi: 10.3390/ijms25147511.
5
Learning from cancer to address COVID-19.从癌症中学习以应对 COVID-19。
Biol Futur. 2023 Jun;74(1-2):29-43. doi: 10.1007/s42977-023-00156-5. Epub 2023 Jul 6.
6
Hybrid-seq deciphers the complex transcriptional profile of the human DNA repair associated gene.杂交测序解析了人类 DNA 修复相关基因的复杂转录谱。
RNA Biol. 2023 Jan;20(1):281-295. doi: 10.1080/15476286.2023.2220210.
7
Adaptive nanopore sequencing to determine pathogenicity of exonic duplication.自适应纳米孔测序确定外显子重复的致病性。
J Med Genet. 2023 Nov 27;60(12):1206-1209. doi: 10.1136/jmg-2023-109155.
8
Decoding cancer and herbal renaissance.解读癌症与草药复兴。
Longhua Chin Med. 2022 Sep;5. doi: 10.21037/lcm-22-12. Epub 2022 Sep 30.
9
Reclassification of Five BRCA1/2 Variants with Unknown Significance Using Complex Functional Study.使用复杂功能研究重新分类五个意义不明的 BRCA1/2 变异体。
Cancer Res Treat. 2022 Oct;54(4):970-984. doi: 10.4143/crt.2021.1078. Epub 2022 Feb 8.
10
Complementary Square-Wave Voltammetry and LC-MS/MS Analysis to Elucidate Induced Damaged and Mutated Mitochondrial and Nuclear DNA from in Vivo Knockdown of the 1 Gene in the Mouse Skeletal Muscle.互补方波伏安法和 LC-MS/MS 分析阐明体内敲除小鼠骨骼肌 1 基因后诱导的受损和突变的线粒体和核 DNA。
Anal Chem. 2021 Aug 24;93(33):11592-11600. doi: 10.1021/acs.analchem.1c02249. Epub 2021 Aug 12.

本文引用的文献

1
BRCA1 splice variants exhibit overlapping and distinct transcriptional transactivation activities.
J Cell Biochem. 2003 May 1;89(1):120-32. doi: 10.1002/jcb.10487.
2
Impaired meiotic DNA-damage repair and lack of crossing-over during spermatogenesis in BRCA1 full-length isoform deficient mice.BRCA1全长异构体缺陷小鼠精子发生过程中减数分裂DNA损伤修复受损及交叉缺失。
Development. 2003 May;130(9):2001-12. doi: 10.1242/dev.00410.
3
Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient mice.Brca1外显子11缺陷小鼠的正常淋巴细胞发育和胸腺淋巴瘤形成
Oncogene. 2003 Jan 30;22(4):528-37. doi: 10.1038/sj.onc.1206208.
4
Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.在缺乏Brca1全长异构体的小鼠中,由p53介导的衰老、老化和恶性转化。
Genes Dev. 2003 Jan 15;17(2):201-13. doi: 10.1101/gad.1050003.
5
The Fanconi anaemia/BRCA pathway.范可尼贫血/乳腺癌易感基因通路。
Nat Rev Cancer. 2003 Jan;3(1):23-34. doi: 10.1038/nrc970.
6
Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans.人类中可变剪接与无义介导的mRNA衰变广泛偶联的证据。
Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):189-92. doi: 10.1073/pnas.0136770100. Epub 2002 Dec 26.
7
Cell cycle differences in DNA damage-induced BRCA1 phosphorylation affect its subcellular localization.DNA损伤诱导的BRCA1磷酸化过程中的细胞周期差异影响其亚细胞定位。
J Biol Chem. 2003 Jan 17;278(3):2015-20. doi: 10.1074/jbc.M208685200. Epub 2002 Nov 8.
8
Cancer Incidence in BRCA1 mutation carriers.携带BRCA1基因突变者的癌症发病率。
J Natl Cancer Inst. 2002 Sep 18;94(18):1358-65. doi: 10.1093/jnci/94.18.1358.
9
Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation.电离辐射后,Atm介导的S期检查点特别需要Brca1中丝氨酸1387的磷酸化。
Cancer Res. 2002 Aug 15;62(16):4588-91.
10
Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour.WT1剪接的变化与肾母细胞瘤中的特定基因表达谱相关。
Oncogene. 2002 Aug 15;21(36):5566-73. doi: 10.1038/sj.onc.1205752.

BRCA1可变剪接的新作用。

Emerging roles of BRCA1 alternative splicing.

作者信息

Orban T I, Olah E

机构信息

National Institute of Oncology, Department of Molecular Genetics, Budapest, H-1122, Hungary.

出版信息

Mol Pathol. 2003 Aug;56(4):191-7. doi: 10.1136/mp.56.4.191.

DOI:10.1136/mp.56.4.191
PMID:12890739
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1187320/
Abstract

Germline mutations of the BRCA1 gene predispose individuals mainly to the development of breast and/or ovarian cancer. However, the exact function of the gene is still unclear, although the encoded proteins are involved in various cellular processes, including transcriptional regulation and DNA repair pathways. Several BRCA1 splice variants are found in different tissues, but in spite of intense investigations, their regulation and possible functions are poorly understood at the moment. This review summarises current knowledge on the roles of these splice variants and the mechanisms responsible for their formation. Because alternative splicing is now widely accepted as an important source of genetic diversity, elucidating the functions of the BRCA1 splice variants would help in the understanding of the exact role(s) of this tumour suppressor. This should help to resolve the current paradox that, despite its seemingly vital cellular functions, mutations of this gene are associated with tissue specific tumour formation predominantly in the breast and the ovary.

摘要

BRCA1基因的种系突变主要使个体易患乳腺癌和/或卵巢癌。然而,尽管该基因编码的蛋白质参与包括转录调控和DNA修复途径在内的多种细胞过程,但其确切功能仍不清楚。在不同组织中发现了几种BRCA1剪接变体,尽管进行了深入研究,但目前对它们的调控和可能功能的了解仍然很少。这篇综述总结了关于这些剪接变体的作用以及其形成机制的当前知识。由于可变剪接现在已被广泛认为是遗传多样性的重要来源,阐明BRCA1剪接变体的功能将有助于理解这种肿瘤抑制因子的确切作用。这应该有助于解决当前的矛盾,即尽管该基因看似具有至关重要的细胞功能,但其突变却主要与乳腺和卵巢的组织特异性肿瘤形成相关。